Atrial Fibrillation (anticoagulation) — EECC MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiologyAtrial Fibrillation (anticoagulation)EECC

A 64-year-old with nonvalvular AF and CHA₂DS₂‑VASc = 3 (HTN, age 64, DM). Normal renal function. Best stroke prevention?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Apixaban

Anticoagulation is recommended for CHA₂DS₂‑VASc ≥2 in men; DOACs (e.g., apixaban) are preferred over warfarin in most patients. Antiplatelet monotherapy is insufficient. Low INR targets are ineffective. No therapy is inappropriate.

Reference: NICE NG196: Atrial fibrillation—diagnosis and management: https://www.nice.org.uk/guidance/ng196/chapter/recommendations